Scientific instrument manufacturer Bruker Corporation (BRKR) has grown revenues by 8% on average over the last three years by investing in R&D and acquisitions. The top line growth has also generated returns for shareholders, with operating earnings growth of 18% per year over the same period.
Slide from Bruker presentation at Stifel 2019 Healthcare Conference
Shareholders have been handsomely rewarded, with the share price almost doubling in the last year. Let's look to see if the growth has run its course or if the growth can continue.
Management
The Laukien